HCM HUTCHMED (China) Limited Earnings and EPS analysis

Relative Growth: Rel. Growth: 6

Relative Strength: Rel. Strength: 72

Relative Valuation: Rel. Valuation: 13

Relative Profitability: Rel. Profitability: 29

EPS in 2026 (TTM): $0.1

Last Report Period Date: Jun 30, 2026

Currently, HCM's current EPS stands at $0.1, according to the most recent financial reports. For the year 2025, HCM reported a per-share earnings of $2.65, which marks an increase compared to the EPS of $0.2 recorded in 2024.

HCM earnings history

Historical annual and quarterly earnings per share (EPS) data for HUTCHMED (China) Limited

EPS (TTM)

$0.1

In 2025, HUTCHMED (China) Limited's EPS was $2.65, an increase of 1,225% from $0.2 in 2024. For the twelve months ending June 2026, the EPS is $0.1. For the year 2024, the yearly earnings per share was $0.2, marking a decrease of 66.7% compared to 2023.

HCM EPS vs price chart

HCM EPS growth history

Earnings per share growth rates over time

EPS growth YoY

1,225%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

HCM Earnings Waterfall

Breakdown of revenue, profit and net income for HUTCHMED (China) Limited

HCM Earnings vs Peers

What are the earnings of HCM compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
BMY Bristol-Myers Squibb Company	13.44	178.7%	5.3%	N/A
NVS Novartis AG	21.43	21.8%	31.2%	15.2%
AZN Astrazeneca plc	24.23	45.4%	46%	22%
AMGN AMGEN Inc	25.04	88.1%	5.6%	2.9%
JNJ Johnson & Johnson	30.83	90.6%	17.7%	14.8%
PFE Pfizer Inc	37.08	-3.5%	-37.4%	-3.7%
LLY Lilly(Eli) & Company	38.57	95.6%	49.2%	27.5%
MRK Merck & Co Inc	116.6	8%	8.4%	21.2%
HCM HUTCHMED (China) Limited	143.7	1,225%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.